Fruit Tree

Fruit Tree is a biotechnology company focused on developing novel therapies for metabolic and genetic disorders, with a primary emphasis on conditions related to sulfur amino acid metabolism. The company's lead research efforts target cystathionine beta-synthase (CBS), aiming to address the underlying biochemical imbalances in patients with homocystinuria and potentially Down syndrome. By utilizing a deep understanding of enzyme kinetics and metabolic pathways, Fruit Tree seeks to create small molecule modulators that can restore normal metabolic function. The company operates as a lean, research-driven entity, often collaborating with academic institutions to advance its early-stage pipeline toward clinical validation.